Idiopathic sudden sensorineural hearing loss: classic cardiovascular and new genetic risk factors

F Ballesteros1, D Tassies, J C Reverter

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, Hospital Clínic, Barcelona, Spain. ferran.ballesteros@gmail.com

Audiology & Neuro-Otology
|September 6, 2012
PubMed

Insights

Idiopathic sudden sensorineural hearing loss (iSSNHL) is linked to a specific gene variant affecting platelet function. Patients with this genetic marker, particularly homozygous individuals, show a poorer recovery prognosis from iSSNHL.

Area of Science:

  • Otolaryngology
  • Genetics
  • Cardiology

Background:

  • The exact cause of idiopathic sudden sensorineural hearing loss (iSSNHL) remains unclear.
  • Clinical observations suggest vascular involvement, but direct evidence is limited due to inner ear study constraints.

Purpose of the Study:

  • To investigate the association between thrombophilic genetic variants impacting platelet function and iSSNHL.
  • To evaluate the cardiovascular risk profile in patients diagnosed with iSSNHL.

Main Methods:

  • 118 Caucasian iSSNHL patients and 161 controls underwent genetic analysis for ITGB3 (PLA1/A2) and ITGA2 (C807T) polymorphisms.
  • Cardiovascular risk was assessed using the Framingham coronary heart disease risk scale.
  • Patient recovery data was collected and analyzed in relation to genetic findings.

Main Results:

  • A higher prevalence of the ITGA2 807T allele was observed in iSSNHL patients compared to controls.
  • The homozygous ITGA2 807TT genotype correlated significantly with a reduced probability of hearing recovery.
  • No association was found between the ITGB3 PLA1/A2 polymorphism and hearing recovery.
  • Patients with iSSNHL did not exhibit an increased prevalence of traditional cardiovascular risk factors.

Conclusions:

  • The 807T thrombophilic polymorphism in platelet glycoprotein Ia/IIa is more common in iSSNHL patients.
  • Homozygosity for the ITGA2 807TT genotype is linked to diminished recovery outcomes in iSSNHL.
  • Conventional cardiovascular risk factors do not appear to be directly related to the development of iSSNHL.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...